Surrozen

Endogena Therapeutics

This biotech company develops small-molecule regenerative medicines to repair tissues and organs for patients with degenerative eye diseases and genetic disorders.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Neuvasq

This company develops Wnt surrogate antibodies to restore blood-brain and blood-retina barriers for patients with vascular retinopathies and neurological disorders.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.

Cirrus Therapeutics

This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.

Vedere Bio

This biotechnology company develops ocular gene therapies to restore functional vision for patients with inherited retinal degenerations and geographic atrophy.

Ollin Bio

This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.